Table 1.
Demographic and clinical characteristics and ratio ofBlastocystis spp.infections in study and control groups
| |
Symptomatic Patients |
Control group |
|||
|---|---|---|---|---|---|
| IBS | IBD | Others | |||
|
Demographic and clinical characteristics | |||||
|
Age (years); mean (SD) |
45.8(16.2) |
45.2(13.2) |
47.3(16.1) |
45.5(15.2) |
|
|
Gender |
|
|
|
|
|
| Male% |
39.6 |
41.8 |
44.9 |
42.4 |
|
| Female% |
60.4 |
58.2 |
55.1 |
57.6 |
|
|
Clinical Symptoms% |
|
|
|
|
|
| Abdominal pain |
79.8 |
83.5 |
81.1 |
|
|
| Constipation |
50.2 |
14.9 |
49.5 |
|
|
| Diarrhea |
34.2 |
89.5 |
48.8 |
|
|
| Bloating |
79.8 |
74.6 |
71.3 |
|
|
| Flatulence |
50.2 |
59.7 |
54.3 |
|
|
|
Blastocystis spp.infections | |||||
| |
B. hominispositivity |
Total |
|||
| |
N |
% |
N |
||
|
Total symptomatic patients |
134 |
5.74 |
2334 |
||
| Symptomatic patients/ undiagnosed |
55 |
4.90 |
1122 |
||
| IBD |
28 |
8.35 |
335 |
||
| UC |
24 |
8.70 |
276 |
||
| CD |
4 |
6.78 |
59 |
||
| IBS |
51 |
5.82 |
877 |
||
| Controls | 6 | 3.12 | 192 | ||
IBS: Irritable bowel syndrome; IBD: Inflammatory bowel disease; UC: Ulcerative colitis; CD: Crohn’s disease.